C4 Therapeutics (CCCC) Assets (2019 - 2025)
Historic Assets for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $265.5 million.
- C4 Therapeutics' Assets fell 2940.28% to $265.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $265.5 million, marking a year-over-year decrease of 2940.28%. This contributed to the annual value of $349.6 million for FY2024, which is 713.21% down from last year.
- As of Q3 2025, C4 Therapeutics' Assets stood at $265.5 million, which was down 2940.28% from $296.5 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Assets ranged from a high of $528.4 million in Q2 2021 and a low of $265.5 million during Q3 2025
- In the last 5 years, C4 Therapeutics' Assets had a median value of $381.1 million in 2024 and averaged $404.4 million.
- Its Assets has fluctuated over the past 5 years, first soared by 12167.23% in 2021, then crashed by 2940.28% in 2025.
- C4 Therapeutics' Assets (Quarter) stood at $506.8 million in 2021, then dropped by 14.98% to $430.8 million in 2022, then decreased by 12.62% to $376.5 million in 2023, then fell by 7.13% to $349.6 million in 2024, then decreased by 24.06% to $265.5 million in 2025.
- Its Assets was $265.5 million in Q3 2025, compared to $296.5 million in Q2 2025 and $319.5 million in Q1 2025.